Detalhe da pesquisa
1.
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
Eur J Nucl Med Mol Imaging
; 51(2): 558-567, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37736808
2.
The tumor core boost study: A feasibility study of radical dose escalation to the central part of large tumors with an integrated boost in the palliative treatment setting.
Strahlenther Onkol
; 199(3): 258-267, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857073
3.
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.
Eur J Nucl Med Mol Imaging
; 50(8): 2529-2536, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905411
4.
Stereotactic body radiotherapy of adrenal metastases-A dose-finding study.
Int J Cancer
; 151(3): 412-421, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35383919
5.
Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
Q J Nucl Med Mol Imaging
; 66(4): 361-371, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32286768
6.
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis.
Int J Cancer
; 149(2): 358-370, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682927
7.
Value of PET imaging for radiation therapy.
Strahlenther Onkol
; 197(9): 1-23, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34259912
8.
Influence of short-term dexamethasone on the efficacy of 177 Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer.
Prostate
; 80(8): 619-631, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32187729
9.
A novel open-source software-based high-precision workflow for target definition in cardiac radioablation.
J Cardiovasc Electrophysiol
; 31(10): 2689-2695, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32648343
10.
Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy.
Strahlenther Onkol
; 196(11): 1006-1017, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32399639
11.
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy.
Eur J Nucl Med Mol Imaging
; 47(10): 2328-2338, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32179961
12.
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy.
BMC Cancer
; 20(1): 362, 2020 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32349700
13.
Comparison of relative and absolute rectal dose-volume parameters and clinical correlation with acute and late radiation proctitis in prostate cancer patients.
Strahlenther Onkol
; 195(2): 103-112, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30191285
14.
Comparison of 68â¯Ga-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer.
Strahlenther Onkol
; 195(5): 420-429, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610354
15.
Patterns of relapse as determined by 68Ga-PSMA ligand PET/CT after radical prostatectomy : Importance for tailoring and individualizing treatment.
Strahlenther Onkol
; 194(4): 303-310, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29134231
16.
Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review.
Strahlenther Onkol
; 194(2): 79-90, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29030654
17.
PSA-stratified detection rates for [68Ga]THP-PSMA, a novel probe for rapid kit-based 68Ga-labeling and PET imaging, in patients with biochemical recurrence after primary therapy for prostate cancer.
Eur J Nucl Med Mol Imaging
; 45(6): 913-922, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29308527
18.
Correction to: Value of PET imaging for radiation therapy.
Strahlenther Onkol
; 198(1): 80-82, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34617130
19.
Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer.
Eur J Nucl Med Mol Imaging
; 44(6): 960-968, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28280856
20.
Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy : Risk-modifying factors.
Strahlenther Onkol
; 192(1): 8-16, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26416291